Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Nicholson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Safety|December 17, 2011
Risk evaluation and mitigation strategies (REMS): educating the prescriberSusan C Nicholson, Janet Peterson, Behin Yektashenas
Pharmacotherapy|June 18, 2002
Antimicrobial-associated acute hepatitisSusan C Nicholson, C Douglas Webb, Robert C Moellering
Journal of Midwifery & Women'S Health|March 10, 2022
Interest in Home Birth During the COVID-19 Pandemic: Analysis of Google Trends DataRu-Fong J Cheng, Alan C Fisher, Susan C Nicholson
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderlySusan C Nicholson, Kevin P High, Samantha Gothelf, et al.
Clinical Therapeutics|July 16, 2002
Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitisAntonio Anzueto, Mark Gotfried, Matthew A Wikler, et al.
Current Medical Research and Opinion|October 24, 2009
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trialsStephen G Jenkins, Alan C Fisher, Janet A Peterson, et al.
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumoniaSusan C Nicholson, Walter R Wilson, Bruce J Naughton, et al.
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacinSusan C Nicholson, C Douglas Webb, Vincent T Andriole, et al.
Current Medical Research and Opinion|April 17, 2010
Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitisMargaret Paglia, Janet Peterson, Alan C Fisher, et al.
Journal of Opioid Management|September 4, 2012
Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use educationSusan C Nicholson, Kimberly Evanyo, Gregory D Salinas, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Safety|December 17, 2011
Risk evaluation and mitigation strategies (REMS): educating the prescriberSusan C Nicholson, Janet Peterson, Behin Yektashenas
Pharmacotherapy|June 18, 2002
Antimicrobial-associated acute hepatitisSusan C Nicholson, C Douglas Webb, Robert C Moellering
Journal of Midwifery & Women'S Health|March 10, 2022
Interest in Home Birth During the COVID-19 Pandemic: Analysis of Google Trends DataRu-Fong J Cheng, Alan C Fisher, Susan C Nicholson
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderlySusan C Nicholson, Kevin P High, Samantha Gothelf, et al.
Clinical Therapeutics|July 16, 2002
Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitisAntonio Anzueto, Mark Gotfried, Matthew A Wikler, et al.
Current Medical Research and Opinion|October 24, 2009
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trialsStephen G Jenkins, Alan C Fisher, Janet A Peterson, et al.
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumoniaSusan C Nicholson, Walter R Wilson, Bruce J Naughton, et al.
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacinSusan C Nicholson, C Douglas Webb, Vincent T Andriole, et al.
Current Medical Research and Opinion|April 17, 2010
Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitisMargaret Paglia, Janet Peterson, Alan C Fisher, et al.
Journal of Opioid Management|September 4, 2012
Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use educationSusan C Nicholson, Kimberly Evanyo, Gregory D Salinas, et al.
Pageof 2